Bicocca Open Archive

Logo unimib boa
MONZA, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.687
AS - Asia 7.809
EU - Europa 4.955
SA - Sud America 887
Continente sconosciuto - Info sul continente non disponibili 855
AF - Africa 146
OC - Oceania 16
Totale 27.355
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.983
VN - Vietnam 2.290
SG - Singapore 2.241
CN - Cina 1.387
IT - Italia 1.370
HK - Hong Kong 806
DE - Germania 801
RU - Federazione Russa 743
BR - Brasile 671
CA - Canada 562
SE - Svezia 503
GB - Regno Unito 326
IE - Irlanda 321
IN - India 221
FR - Francia 220
BD - Bangladesh 148
KR - Corea 138
UA - Ucraina 113
FI - Finlandia 109
ID - Indonesia 104
TR - Turchia 94
AR - Argentina 78
DK - Danimarca 71
JP - Giappone 69
NL - Olanda 61
ES - Italia 57
IQ - Iraq 55
MX - Messico 52
AT - Austria 51
LT - Lituania 51
ZA - Sudafrica 51
CO - Colombia 41
SA - Arabia Saudita 40
PL - Polonia 35
PK - Pakistan 32
BE - Belgio 30
EC - Ecuador 27
PH - Filippine 24
VE - Venezuela 24
CH - Svizzera 23
PY - Paraguay 19
CR - Costa Rica 17
MA - Marocco 17
ET - Etiopia 16
MY - Malesia 16
UZ - Uzbekistan 16
IR - Iran 15
JM - Giamaica 14
KZ - Kazakistan 13
AU - Australia 12
EG - Egitto 11
NP - Nepal 11
TN - Tunisia 11
CL - Cile 10
CZ - Repubblica Ceca 10
TW - Taiwan 10
AZ - Azerbaigian 9
KE - Kenya 9
PR - Porto Rico 9
TT - Trinidad e Tobago 9
GT - Guatemala 8
HR - Croazia 8
IL - Israele 8
JO - Giordania 8
RO - Romania 8
BG - Bulgaria 7
DZ - Algeria 7
GR - Grecia 7
KG - Kirghizistan 7
SV - El Salvador 7
UY - Uruguay 7
PA - Panama 6
PT - Portogallo 6
RS - Serbia 6
AO - Angola 5
EU - Europa 5
OM - Oman 5
PE - Perù 5
AE - Emirati Arabi Uniti 4
BB - Barbados 4
BH - Bahrain 4
BO - Bolivia 4
CW - ???statistics.table.value.countryCode.CW??? 4
HN - Honduras 4
HU - Ungheria 4
LB - Libano 4
LY - Libia 4
MN - Mongolia 4
NI - Nicaragua 4
NZ - Nuova Zelanda 4
TH - Thailandia 4
AL - Albania 3
BZ - Belize 3
EE - Estonia 3
LA - Repubblica Popolare Democratica del Laos 3
MM - Myanmar 3
SC - Seychelles 3
SY - Repubblica araba siriana 3
AM - Armenia 2
BN - Brunei Darussalam 2
Totale 26.474
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.891
Singapore 1.392
Ashburn 1.263
San Jose 919
Dallas 875
Hong Kong 778
Ho Chi Minh City 668
Hanoi 575
Frankfurt am Main 517
Milan 504
Council Bluffs 389
Toronto 385
Wilmington 370
Chandler 358
Woodbridge 316
Dublin 310
Los Angeles 294
New York 281
Dearborn 246
Santa Clara 224
Fairfield 213
Houston 200
Beijing 173
Chicago 152
Princeton 141
Boardman 139
Nanjing 116
Jacksonville 113
Seattle 110
Seoul 110
The Dalles 108
Hefei 105
Rome 89
Columbus 88
Buffalo 82
Lauterbourg 78
Shanghai 77
Da Nang 76
Jakarta 73
Guangzhou 72
Moscow 68
Cambridge 66
Orem 63
Haiphong 61
Helsinki 58
São Paulo 58
Munich 50
Dong Ket 49
Montreal 46
Phoenix 46
Biên Hòa 44
Basingstoke 43
Ha Long 42
Atlanta 41
Vilnius 40
Brooklyn 38
Denver 38
Nanchang 38
Tokyo 38
Vienna 36
Hải Dương 35
Lawrence 35
Ninh Bình 35
Nuremberg 35
Bắc Giang 34
Hangzhou 33
Pune 33
Altamura 32
Quận Bình Thạnh 32
Can Tho 31
Shenyang 31
Chennai 30
London 29
Vũng Tàu 29
Baghdad 28
Warsaw 28
Zhengzhou 27
Rio de Janeiro 26
Carate Brianza 24
Johannesburg 24
Thái Nguyên 24
Tianjin 24
Brussels 23
San Diego 23
Stockholm 22
Washington 22
Ottawa 21
Poplar 21
Shangdi 21
Andover 20
Fremont 20
Manchester 20
Phủ Lý 20
Quận Một 20
Kunming 19
San Francisco 19
Turku 19
Changsha 18
Kent 18
Quận Phú Nhuận 18
Totale 16.856
Salva come PNG Salva come JPEG
Nome #
Paclitaxel alters the microvascular network in the central and peripheral nervous system of rats with chemotherapy-induced painful peripheral neuropathy 621
CHARACTERIZATION OF AXONAL DEGENERATION MECHANISMS IN BORTEZOMIB-TREATED SENSORY NEURONS 592
Head down tilt 15° in experimental intracerebral hemorrhage: a randomized non-inferiority safety trial 581
INSIGHT ON BORTEZOMIB INDUCED MICROTUBULES STABILITY AND MITOCHONDRIAL TRAFFICKING 525
Head Down Tilt 15° in Acute Ischemic Stroke with Poor Collaterals: A Randomized Preclinical Trial 521
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 502
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 462
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 447
Selective Cerebrospinal Fluid Hypothermia: Bioengineering Development and In Vivo Study of an Intraventricular Cooling Device (V-COOL) 443
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 438
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 425
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 413
Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy 412
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 409
Cerebral collateral flow defines topography and evolution of molecular penumbra in experimental ischemic stroke 397
Cerebral collateral flow defines topography and evolution of molecular penumbra in experimental ischemic stroke 393
Multi-site laser Doppler flowmetry for assessing collateral flow in experimental ischemic stroke: Validation of outcome prediction with acute MRI 393
In vitro models for studying oxaliplatin neurotoxic effects 393
Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy 387
Givinostat-Liposomes: Anti-Tumor Effect on 2D and 3D Glioblastoma Models and Pharmacokinetics 383
An in vitro model of dorsal root ganglion (DRG) neurons to investigate the molecular mechanisms of oxaliplatin-induced peripheral neuropathy. 379
Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation 366
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 358
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage? 355
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 355
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 354
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 353
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 350
Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity 346
Cerebral collateral therapeutics in acute ischemic stroke: A randomized preclinical trial of four modulation strategies 345
Incubation with low doses of oxaliplatin modifies the electrophysiological properties of dorsal root ganglion neurons 341
Morpho-Functional Characterisation of the Rat Ventral Caudal Nerve in a Model of Axonal Peripheral Neuropathy 338
An in vivo and in vitro neurophysiological approach to acute and chronic oxaliplatin-induced peripheral neurotoxicity 333
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 330
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 327
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 326
Macrophage infiltration in different preclinical models of chemotherapy-induced peripheral neurotoxicity 322
MITOCHONDRIAL DYSFUNCTION IS A FEATURE OF PACLITAXEL AND OXALIPLATIN-PROMOTED CHEMOTHERAPY-INDUCED PERIPHERAL NEUROTOXICITY 321
Pravastatin acute neuroprotective effects depend on blood brain barrier integrity in experimental cerebral ischemia 319
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 317
Molsidomide provides neuroprotection against vincristine-induced peripheral neurotoxicity 317
Morphological and functional assessment of NCX2 potential role in axonal damage related to Oxaliplatin 313
Addressing the Need of a Translational Approach in Peripheral Neuropathy Research: Morphology Meets Function 308
NCX2 modulation to prevent axonal damage related to Oxaliplatin-induced peripheral neurotoxicity 307
Morphological and functional study of the caudal nerve in a rat model of peripheral neuropathy 307
Multimodal experimental approach to the study of human neurological diseases 301
Thermal plantar test in experimental ischemic stroke 295
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 293
Study of perpheral neurotoxicity of different doses of oxaliplatin in cd1 mice 291
Studying the caudal nerve anatomy and physiology to refine detection of peripheral nerve damage in rodent models. 286
Cerebral collateral therapeutics in experimental ischemic stroke: a randomized preclinical trial of four modulation strategies 280
7T MRI first exploitation in a chemotherapy induced peripheral neurotoxicity in vivo model. 278
Head down tilt 15° to preserve salvageable brain tissue in acute ischemic stroke: A pre-clinical pooled analysis, with focus on cerebral hemodynamics 271
Ivig Effect In A Wistar Rat Model Of Bortezomib-Induced Peripheral Neuropathy 271
DIFFERENT DEGREES OF MACROPHAGE INFILTRATION IN PRECLINICAL MODELS OF ANTITUBULIN AGENTS-INDUCED PERIPHERAL NEUROTOXICITY 265
INVESTIGATING THE INVOLVEMENT OF SATELLITE GLIAL CELLS IN PACLITAXEL-INDUCED PERIPHERAL NEUROTOXICITY 263
A Possible role of OCT2 gene in the development of peripheral neurotoxicity induced by cisplatin 260
EVALUATION OF THE EFFICACY OF PERIPHAGEN NEUROTROPHIN-3 EXPRESSING VECTOR FOR OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY. 259
Pathogenesis of platinum-induced peripheral neurotoxicity: Insights from preclinical studies 256
Tackling Oxaliplatin Induced Peripheral neurotoxicity: from bed to bench side and back. 250
ACCURATE NEUROPHYSIOLOGICAL MONITORING FOR SENSORY NEUROPATHY IN MOUSE MODELS OF CHEMOTHERAPY INDUCED PERIPHERAL NEUROTOXICITY 249
Blood neurofilament light chains as a potential damage marker in chemotherapy-induce peripheral neuropathy rodent models 244
Topiramate Prevents Oxaliplatin Neurotoxicity in a rat model 244
Oxaliplatin induced peripheral neurotoxicity (OIPN): a translational approach for drug discovery. 242
Intravenous Immunoglobulin Preparation Attenuates Pain Behaviors in a Wistar Rat Model of Bortezomib-Induced Peripheral Neuropathy 240
Translating morphology from bench side to bed side via neurophysiology: 8-minute protocol for peripheral neuropathy research 234
NERVE EXCITABILITY TESTING AS THE LINK BETWEEN ANATOMY AND PHYSIOLOGY: AXONAL EXCITABILITY TESTING TO TEST IN VIVO MECHANISMS OF PERIPHERAL NERVE DAMAGE. 233
Advanced neurophysiology - a translational approach to neuropathy and neuropathic pain 232
Pharmacokinetics of IVIg in Wistar rats 231
Erratum: Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy (Proceedings of the National Academy of Sciences of the United States of America (2021) 118 (e2012685118) DOI: 10.1073/pnas.2012685118) 229
How to assess models of oxaliplatin induced peripheral neurotoxicity – a neurophysiological translational approach 228
Human Immunoglobulins ameliorate pain in rats with bortezomib-induced peripheral neuropathy 228
Early stimulation of trek channel transcription and activity induced by oxaliplatin-dependent cytosolic acidification 224
Ghrelin agonist HM01 attenuates chemotherapy-induced neurotoxicity in rodent models 220
EMG Recordings at Rest to Verify Axonal Hyperexcitability in a Rat Model of Oxaliplatin Induced Peripheral Neurotoxicity 219
A mechanistic understanding of the relationship between skin innervation and chemotherapy-induced neuropathic pain 216
STANDARD AND ADVANCED NEUROPHYSIOLOGY SET UP IN MOUSE MODELS: SENSORY RECORDINGS AND NERVE EXCITABILITY TESTING OF THE CAUDAL NERVE. 201
An innovative traslational approach to oxaliplatin induced peripheral neurotoxicity in animal models: nerve excitability testing. 199
Neurofilament light protein: a blood biomarker of neurodegeneration in chemotherapy-induced peripheral neurotoxicity. 197
Topiramate neuroprotectant effects against oxaliplatin induced peripheral neurotoxicity 194
MORPHOFUNCTIONAL CHARACTERIZATION OF CIPN 193
Oxaliplatin induced Peripheral Neurotoxicity (OIPN): a Rat Model that full encompasses all OIPN Phenomena 183
UNVEILING THE MICROVASCULAR NETWORK ALTERATIONS IN THE CENTRAL AND PERIPHERAL NERVOUS SYSTEM OF RATS EXPOSED TO NEUROTOXIC CHEMOTHERAPY 182
Nerve Excitability Testing: An In Vivo Translational Approach To Investigate Oxaliplatin Induced Peripheral Neurotoxicity Pathogenesis And Treatment 182
Oxaliplatin induced peripheral neurotoxicity: nerve excitability testing full profile in a long term toxicity animal study 177
The Link between Bench and Bed-Side: “clinical” neurophysiological approach to a rat model of neuropathy 152
TOPIRAMATE PREVENTS OXALIPLATIN ACUTE PERIPHERAL NEUROTOXICITY. 139
Totale 27.355
Salva come PNG Salva come JPEG
Categoria #
all - tutte 80.940
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.940
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022788 0 0 0 116 84 96 60 54 49 63 84 182
2022/20231.828 198 362 223 187 155 304 58 84 120 31 64 42
2023/20241.293 56 46 59 76 144 292 191 75 63 32 40 219
2024/20253.884 163 470 343 160 320 141 300 138 422 582 318 527
2025/202611.294 2.150 1.027 1.215 871 992 538 1.477 397 676 785 591 575
2026/20272.541 255 377 911 998 0 0 0 0 0 0 0 0
Totale 27.355